| Home > Zentren > Zentrum für Innere Medizin > I. Medizinische Klinik und Poliklinik > Publikationen > 2006
Berg T, von Wagner M, Nasser S, Sarrazin C, Heintges T, Gerlach T, Buggisch P, Goeser T, Rasenack J, Pape GR, Schmidt WE, Kallinowski B, Klinker H, Spengler U, Martus P, Alshuth U, Zeuzem S.
Extended Treatment Duration for Hepatitis C Virus Type 1: Comparing 48 Versus 72 Weeks of Peginterferon-Alfa-2a Plus Ribavirin.
Gastroenterology 2006;130:1086-1097
http://www.ncbi.nlm.nih.gov/sites/entrez/16618403
Bläker M, de Weerth A.
Octreotide versus Octreotide plus interferon-alpha in endocrine gastroenteropancreatic tumors.
Zeitschrift für Gastroenterologie 2006;44:1003-4
http://www.ncbi.nlm.nih.gov/sites/entrez/16981075
Buggisch P, Feucht HH, Denzer U, Petersen J, Schramm C, Seitz U, Sterneck M, de Weerth A, Zöllner B:
Leberkrankheiten (Teil I) - Chronische Hepatitis, Komplikationen der Zirrhose und ihre Behandlung.
Hamburger Ärzteblatt 2006;3:139-147
Burchard GD.
Malaria.
Internist (Berl). 2006 Aug;47(8):818-824.
http://www.ncbi.nlm.nih.gov/sites/entrez/16819659
Czochra P, Klopcic B, Meyer E, Herkel J, Garcia-Lazaro JF, Thieringer F, Schirmacher P, Biesterfeld S, Galle PR, Lohse AW, Kanzler S.
Liver fibrosis induced by hepatic overexpression of PDGF-B in transgenic mice.
J Hepatol 2006; 45: 419-428.
http://www.ncbi.nlm.nih.gov/sites/entrez/16842882
Denzer U
Leberpunktion.
Gastroenterologie in Klinik und Praxis.
Hrsg. Riemann, Fischbach, Galle, Mössner.
Thieme Verlag
Denzer U
Leberbiopsie: Indikation, Stellenwert, Durchführung, Befundinterpretation.
Gastroenterologie update. 2006;3:219-228.
Denzer U, Guthoff A, Wege H, Hillert C, Krupski G. Leberkrankheiten Teil II - Das hepatozelluläre Karzinom.
Hamburger Ärzteblatt 2006;4:207-213
Ehrhardt S, Burchard GD, Mantel C, Cramer JP, Kaiser S, Kubo M, Otchwemah RN, Bienzle U, Mockenhaupt FP.
Malaria, anemia, and malnutrition in African children - defining intervention priorities.
J Infect Dis. 2006 Jul 1;194(1):108-14.
http://www.ncbi.nlm.nih.gov/sites/entrez/16741889
Ehrhardt S, Burchard GD.
Malaria und Reiseimpfungen - ein Update. 2006.
DERM Praktische Dermatologie.
Ehrhardt S, Burchard GD.
Malaria bei Kindern. Prophylaxe und Therapie.
Pädiat. Prax. 68, 463-472 (2006).
Ehrhardt S, Burchard GD.
Miltefosin (Impavido®) zur Behandlung der viszeralen Leishmaniasis.
Arzneiverordnung in der Praxis - Band 33, Ausgabe 2. April 2006
Ehrhardt S, Lippert U, Burchard GD, Sudeck H.
Orchitis as an unusual manifestation of human African trypanosomiasis.
J Infect. 2006 Jan;52(1):e31-3.
http://www.ncbi.nlm.nih.gov/sites/entrez/15936085
Frenzel C, Herkel J, Lüth S, Galle PR, Schramm C, Lohse AW.
Evaluation of F-actin ELISA for the diagnosis of autoimmune hepatitis.
Am J Gastroenterol 2006;101:2731-2736.
http://www.ncbi.nlm.nih.gov/sites/entrez/17227520
Hofbauer LC, Schrader J, Niebergall U, Viereck V, Burchert A, Horsch D, Preissner KT, Schoppet M.
Interleukin-4 differentially regulates osteoprotegerin expression and induces calcification in vascular smooth muscle cells.
Thromb Haemost 2006;95:708-14.
http://www.ncbi.nlm.nih.gov/sites/entrez/16601843
Huber S, Schramm C.
TGFbeta and regulatory T cells.
Front Biosci 2006;11:1014-23.
http://www.ncbi.nlm.nih.gov/sites/entrez/16146793
Lissen E, Clumeck N, Sola R, Mendes-Correa M, Montaner J, Nelson M, Depamphilis J, Pessoa M, Buggisch P, Main J, Dieterich D.
Histological response to pegIFNalpha-2a (40KD) plus ribavirin in HIV-hepatitis C virus co-infection.
AIDS. 2006;20:2175-2181.
http://www.ncbi.nlm.nih.gov/sites/entrez/17086057
Lueth S, Lohse AW.
Autoimmune hepatitis.
Clin Med. 2006 Jan-Feb;6(1):25-8.
http://www.ncbi.nlm.nih.gov/sites/entrez/16521352
Lüth S, Birklein F, Schramm C, Herkel J, Hennes E, Müller-Forell W, Galle P, Lohse AW.
Multiplex Neuritis in a patient with Autoimmune Hepatitis.
World J Gastroenterol 2006; 12: 5396-5398.
http://www.ncbi.nlm.nih.gov/sites/entrez/16981276
Lüth S, Lohse AW, Herkel J.
Transgenic overexpression of murine 60 kDa heat shock protein in the liver does not prevent type I diabetes in NOD mice.
Diabetologia 2006; 49: 1123-1124.
http://www.ncbi.nlm.nih.gov/sites/entrez/16547598
Mockenhaupt FP, Cramer JP, Hamann L, Stegemann MS, Eckert J, Oh NR, Otchwemah RN, Dietz E, Ehrhardt S, Schroder NW, Bienzle U, Schumann RR.
Toll-like receptor (TLR) polymorphisms in African children: Common TLR-4 variants predispose to severe malaria.
Proc Natl Acad Sci U S A. 2006 Jan 3;103(1):177-82.
http://www.ncbi.nlm.nih.gov/sites/entrez/16371473
Neurath M, Lohse AW
Checkliste Anamnese und klinische Untersuchung
Thieme Verlag, Stuttgart, 2. Auflage 2006
Otto G, Herber S, Heise M, Lohse AW, Mönch C, Bittinger F, Hoppe-Lotichius M, Schuchmann M, Victor A, Pitton M.
Response to transarterial chemoembolization as a biological selection criterion for liver transplantation in hepatocellular carcinoma.
Liver Transpl. 2006 Aug;12(8):1260-7.
http://www.ncbi.nlm.nih.gov/sites/entrez/16826556
Pace A, Müller M, Behrke K, Bläker M, Lohse AW, de Weerth A.
Die Focal Adhesion Kinase FAK spielt eine zentrale Rolle in der Vermittlung Wachstumsfaktoren- und G-Protein vermittelter Signale in Pankreaskarzinomen.
Zeitschrift für Gastroenterologie 2006;44:751
Pace A, Tapia JA, Garcia-Marin LJ, Jensen RT.
The Src family kinase, Lyn, is activated in pancreatic acinar cells by gastrointestinal hormones/neurotransmitters and growth factors which stimulate its association with numerous other signaling molecules.
Biochim Biophys Acta. 2006;1763:356-65.
http://www.ncbi.nlm.nih.gov/sites/entrez/16713446
Reisinger EC, Burchard GD.
[Infectiology and tropical medicine -- new developments 2006].
Dtsch Med Wochenschr. 2006 Jun 23;131(25-26):1474-8.
http://www.ncbi.nlm.nih.gov/sites/entrez/16794980
Schmiedel S, Ehrhardt S, Moll I, Burchard GD.
A Thai patient with generalised inflammatory skin disease 18 years after migration to Europe.
Lancet. 2006 Apr 29;367(9520):1458.
http://www.ncbi.nlm.nih.gov/sites/entrez/16650656
Schramm C, Herkel J, Beuers U, Kanzler S, Galle PR, Lohse AW: Pregnancy in autoimmune hepatitis: outcome and risk factors.
Am J Gastroenterol 2006; 101: 556-560.
http://www.ncbi.nlm.nih.gov/sites/entrez/16464221
Schuchmann, M., Schulze-Bergkamen, H., Fleischer, B., Schattenberg, J. M., Siebler, J., Weinmann, A., Teufel, A., Worns, M., Fischer, T., Strand, S., Lohse, A. W., Galle, P. R.
Histone deacetylase inhibition by valproic acid down-regulates c-FLIP/CASH and sensitizes hepatoma cells towards CD95- and TRAIL receptor-mediated apoptosis and chemotherapy.
Oncol Rep 2006 Jan; 15(1): 227-30
http://www.ncbi.nlm.nih.gov/sites/entrez/16328060
Stark K, Herrmann U, Ehrhardt S, Bienzle U.
A syringe exchange programme in prison as prevention strategy against HIV infection and hepatitis B and C in Berlin, Germany.
Epidemiol Infect. 2006 Aug;134(4):814-9.
http://www.ncbi.nlm.nih.gov/sites/entrez/16371183
Teufel A, Wörns M, Weinmann A, Centner C, Piendl A, Lohse AW, Galle PR, Kanzler S.
Genetic association of autoimmune hepatitis and human leucocyte antigen in German patients.
World J Gastroenterol. 2006 Sep 14;12(34):5513-6.
http://www.ncbi.nlm.nih.gov/sites/entrez/17006990
Troeger H, Epple HJ, Schneider T, Wahnschaffe U, Ullrich R, Burchard GD, Jelinek T, Zeitz M, Fromm M, Schulzke JD.
Effect of chronic Giardia lamblia infection on epithelial transport and barrier function in human duodenum.
Gut. 2006 Aug 25;.
http://www.ncbi.nlm.nih.gov/sites/entrez/16935925
Wang C, Teufel A, Cheruti U, Grötzinger J, Galle PR, Lohse AW, Herkel J. Characterisation of human gene encoding SLA/LP autoantigen and its conserved homologues in mouse, fish, fly and worm.
World J Gastroenterol 2006; 12: 902-907.
http://www.ncbi.nlm.nih.gov/sites/entrez/16521218
Weinke T, Liebold I, Burchard GD, Fruhwein N, Grobusch MP, Hatz C, Kollaritsch H, Nothdurft HD, Reisinger E, Rieke B, Schonfeld Ch, Steffen R, Stich A.
Prophylactic immunization against enterotoxin-forming Escherichia coli travellers' diarrhea and cholera: does it make sense and for whom?
Dtsch Med Wochenschr. 2006 Jul 28;131(30):1660-4.
http://www.ncbi.nlm.nih.gov/sites/entrez/16850383
Wiegand J, Buggisch P., Boecher W., Zeuzem S.,Gelbmann C.M., Berg T, Kauffmann W., Kallinowski B., Cornberg M., Jaeckel E, Wedemeyer H, Manns M. P., German HEP-NET Acute HCV Study Group.
Early monotherapy with pegylated interferon alpha-2b for acute hepatitis C infection: The HEP-NET acute-HCV-II study.
Hepatology 2006;43:250-256
http://www.ncbi.nlm.nih.gov/sites/entrez/16440367
Wörns MA, Lohse AW, Neurath MF, Croxford A, Otto G, Kreft A, Galle PR, Kanzler S.
Five cases of de novo inflammatory bowel disease after orthotopic liver transplantation.
Am J Gastroenterol. 2006 Aug;101(8):1931-7.
http://www.ncbi.nlm.nih.gov/sites/entrez/16790037
Wursthorn K, Buggisch P, Lutgehetmann M, Zollner B, Petersen J. : Temporary HBV-resolution in an HIV coinfected patient during HBV-directed combination therapy followed by relapse of HBV.
Antivir Ther. 2006;11:647-52.
http://www.ncbi.nlm.nih.gov/sites/entrez/16964835
Wursthorn K., Lutgehetmann M., Dandri M., Volz T., Buggisch P., Zöllner B., Longerich T., Schirmacher P., Metzler F., Zankel M., Fischer C., Currie G., Brosgart C., Petersen J.
Peginterferon Alpha-2b plus Adefovir induce strong cccDNA decline and HbsAg reduction in patients with chronic Hepatitis B.
Hepatology 2006;44:675-684.
http://www.ncbi.nlm.nih.gov/sites/entrez/16941693
